Lee Schwartzberg, MD

Remote monitoring with tailored texts improved endocrine therapy adherence among breast cancer survivors with low symptom-management self-efficacy, with benefits becoming nonsignificant at higher self-efficacy levels.

Ten percent of patients abandon newly initiated oral oncolytics at the pharmacy. Patients facing higher cost sharing or increased concurrent prescription activity have a higher abandonment rate.